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There continues to be keen interest in 
assessing quality of life (QoL) after 
cystectomy and urinary diversion, given the 
recent evidence-based analyses [1,2] and 
systematic reviews [3–6] evaluating QoL 
studies in this population. A resounding 
characteristic of contemporary reports 
is the preponderance of cross-sectional, 
retrospective, single-institution studies. Very 
few prospective longitudinal studies and no 
randomized controlled trials have been 
reported, greatly limiting the ability to draw 
conclusions from reported observations. 
Despite this limitation, most of these studies 
show similarly favourable overall QoL after 
cystectomy, irrespective of the chosen urinary 
diversion.
As clinicians struggle with existing reports 
that fail to suggest a superior type of 
diversion, patients continue to face the 
ominous task of selecting a diversion that will 
almost certainly affect their urinary function 
for the remainder of their lives. The challenge 
for urologists is to take the suboptimal 
medical reporting, objectively relay the 
information to patients, and facilitate 
integration of this information into the 
patient’s decision-making process. Thus an 
understanding of this decision process is 
essential.
The examination of patient decision-making 
has gained increasing attention in the recent 
past. As a result, the medical community has 
become aware of the importance of health 
knowledge, communication and improved 
patient–physician encounters, all factors that 
improve patient education and permit 
patients to seek greater engagement in 
healthcare choices. Coupling accurate health 
information with high-quality decision 
counselling helps patients to understand the 
potential risks, benefits and uncertainties of 
clinical options, and assists them in selecting 
the option that best accommodates their 
personal preferences. Difficulty in interpreting 
information about risks can lead patients 
to make treatment decisions that are 
incompatible with their preferences, resulting 
in a decline in patient care and satisfaction.
Patients facing radical surgical treatment for 
high-risk bladder cancer have substantial 
fears about body image, sexuality and urinary 
function. These concerns not only involve 
potentially negative perceptions of their 
future health and functional well-being, but 
also encompass uncertainties about the 
practical impact of treatment and recovery on 
family members. These issues can greatly 
influence the choice of treatment and 
diversion, resulting in patient withdrawal 
from health decisions, limited treatment- 
seeking behaviour and potential delays in 
treatment delivery. For these reasons, it is 
imperative that urologists accurately counsel 
patients about the long-term experiences 
with various urinary diversions, to realistically 
set patient, spousal and family expectations in 
an attempt to ensure long-term satisfaction 
and willing adaptation.
 
QoL AFTER URINARY DIVERSION
 
Urinary tract reconstruction attempts to 
provide an acceptable alternative to the 
native bladder by creating adequate storage 
and continence or a reasonable conduit. 
Clinicians have presumed that the 
development of orthotopic continent 
diversions would replicate the normal voiding 
pattern and provide improved QoL over the 
incontinent cutaneous diversion. As a result, 
orthotopic diversion has globally become the 
most common type of urinary diversion 
performed after cystectomy in patients with 
bladder cancer (Fig. 1). Although surgical 
practice patterns have changed, reflecting 
trends towards orthotopic diversion, a real 
improvement in patient QoL has been difficult 
to show.
Recently, a consensus conference convened 
by the WHO and the Société Internationale 
d’Urologie met to review world reports on 
urinary diversion [2]. No level 1 evidence was 
available within the reports and very few level 
2 citations were found, leaving the committee 
to rely heavily on expert opinion and single-
institution retrospective studies. This review, 
as supported by others, could not show 
any superiority of orthotopic diversion or 
continent cutaneous diversion over the ileal 
conduit [1–6]. Without randomized clinical 
trials or well-designed prospective 
longitudinal studies, the optimum form 
of urinary diversion remains unknown. 
Unfortunately, several major challenges make 
the traditional randomized trial impractical in 
this setting. Both patient and provider biases 
and expectations would greatly hamper 
randomization of sometimes frail patients 
with a multitude of comorbidities. Given the 
number of individual patient and family 
factors that enter into the choice of urinary 
diversion, it might be more realistic to study 
differences between diversion populations 
with a well-designed prospective study 
using a design founded on practice-based 
evidence [7]. This type of design provides 
comprehensive practice-based evidence 
for clinical practice improvement by 
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incorporating natural variation within data 
from routine clinical practice.
Despite the limitations in existing QoL studies, 
it is imperative that patients be informed not 
only about the perioperative risks and 
anatomical limitations of each type of urinary 
diversion, but also about short- and long-
term outcomes, so an adequate choice 
of diversion can be made. Although 
retrospective studies suggested that patients 
with ileal conduit diversions have good 
acceptance of their stoma and overall good 
QoL, there remains a sense of uneasiness 
because of fear of urine leakage, skin 
problems, altered body image and sexual 
dysfunction, as described by both men and 
women [1]. Also, bowel disturbance and UTI 
appear to be increased over those in control 
populations. Early studies using primarily 
unvalidated instruments compared ileal 
conduit and continent cutaneous diversion 
[1]. These studies confirmed that stomal 
problems were more common in patients with 
a conduit; however, adjustment and 
satisfaction with current life did not differ 
between groups. There was substantial 
compromise of sexual life of the patients in 
both groups. Ultimately, both incontinent and 
continent cutaneous diversions have high 
perceived overall satisfaction at 1 year [8].
More recently, the importance of using valid 
and reliable instruments to assess QoL has 
become clear, even in the retrospective, 
single-institution study. Various validated 
instruments have thus been developed and 
used to evaluate QoL of patients with urinary 
diversion (Table 1) [9–14]. In this setting, 
comparisons of the ileal conduit diversion and 
the orthotopic neobladder still have not 
shown major differences in QoL, although 
some have reported a greater concern about 
urinary leakage in patients with a conduit, 
despite having leakage less commonly than 
patients with a neobladder [1]. Others suggest 
that patients with a conduit have a poorer 
body image, but overall satisfaction has been 
high in these patients, and notably similar to 
the overall satisfaction of those undergoing 
orthotopic diversion [1–6,15,16]. Only one 
study has suggested a clear QoL benefit in 
patients undergoing orthotopic diversion.
In a study of 102 (69 neobladder and 33 





retrospectively examined postoperative QoL 
using the European Organization for the 
Research and Treatment of Cancer (EORTC) 
QoL Core Questionnaire (QLQ-C30) and an 
unvalidated local questionnaire. In this series, 
patients undergoing orthotopic diversion 
had significantly better adaptation, self-
confidence and rehabilitation than those with 
an ileal conduit. In addition, patients with a 
neobladder had greater restoration of leisure, 
professional and social activities than those 
undergoing ileal conduit diversion. Moreover, 
97% of those with a neobladder would 
recommend their diversion type to a friend, 
compared with only 36% of those with an 
ileal conduit. However, the median follow-up 
might have contributed to differences in this 
cross-sectional study, with the follow-up 
being substantially longer in the conduit 
group (56 months) than in the neobladder 
group (28 months).
Apart from this series, most of the experience 
at the institutional level reflects similar QoL in 
patients undergoing ileal conduit, continent 
cutaneous and orthotopic diversions [1–6]. 
The lack of qualitative differences in QoL lends 
credibility to the theory that patients adapt to 
their diversion over time and have generally 
high satisfaction if they have accurate 
pretreatment expectations of the 
‘performance’ of their diversion.
 
ADMINISTRATION OF QoL SURVEYS
 
When considering the best time to evaluate 
QoL after cystectomy and urinary diversion, 
one must consider the time required to 
restore psychological and health-related QoL 





[18] prospectively evaluated 68 patients 
undergoing radical cystectomy for bladder 
cancer. In an effort to determine the time 
required for these patients to adapt to their 
new health status, they administered the Beck 
Depression Inventory and the EORTC QLQ-C30 
before and at 3, 6 and 12 months after 
surgery, and then every 6 months thereafter. 
The mean (range) follow-up was 28 (12–46) 
months. Psychological and health-related QoL 
measures returned to baseline values after 
12 months, suggesting that either QoL 
improves to a baseline level at 12 months, or 
that it takes that long for patients to adapt 
to their status after cystectomy. In either 
case, QoL instruments are less likely to be 
informative when administered before this 
time.
In comparing QoL studies, one must also 
consider the confounding methods used to 
measure patient responses. Use of a face-to-
face interview, telephone interview and home 
survey with a disease-specific questionnaire 
might give differing results. Office 
questionnaires remain attractive to optimize 
response rates and minimize missing data. 
However, although potentially more 
cumbersome, it is most advantageous to 





Historically, the assessment of QoL after 
urinary diversion was hampered by a lack of 
valid and reliable tools to measure bladder 
cancer-related QoL, resulting only in 
speculation about the outcomes of diversion. 
In the recent past, several tools have been 
developed (Table 1) to measure general and 
cancer-specific QoL. The sensitivity of these 
instruments to distinguish differences in QoL 
between patients with conduit, orthotopic 
and continent cutaneous diversions remains 
unclear. However, several institutions have 
attempted to adapt earlier versions of general 
or cancer-specific instruments to try to 
improve this sensitivity, creating bladder 
cancer-specific instruments. The ultimate 
success of these instruments certainly 
depends on consideration of several aspects 
of the patient’s outcome, and expectations of 
patients and providers, as well as attention to 
recurring limitations in QoL assessments and 
necessary remedies (Table 2).
The Functional Assessment of Incontinence 
Therapy (FACT)-Vanderbilt Cystectomy Index 
represents the first treatment-specific QoL 
measure for patients undergoing cystectomy 
[9]. The 45-item questionnaire comprises the 
FACT-General [10], four questions from the 




Worldwide experience with urinary diversion 
after cystectomy for bladder cancer, from an 
international consensus panel on urinary diversion. 
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the FACT-Colorectal [11] and seven from the 
FACT-Urinary, all validated instruments. 
Preliminary results from an ongoing 
prospective study using this cystectomy-
specific instrument suggest that patients with 
a neobladder have a higher QoL at baseline 
and 1 year after cystectomy than those 
undergoing ileal conduit diversions. However, 
at 1 year, patients with a conduit have a 
consistent improvement in scores over their 
initial presentation, while those with a 
neobladder do not; additional studies are 
forthcoming.
The Bladder Cancer Index (BCI) represents the 
next generation of QoL assessment, developed 
as a reliable and valid QoL instrument for 
patients with bladder cancer managed with 
endoscopic, intravesical or radical surgical 
treatments [12]. The instrument was 
developed using standard psychometric 
methods; it consists of 34 items with three 
primary domains measuring urinary, bowel, 
and sexual health, and two subdomains, 
function and bother. Recently the BCI was 
administered retrospectively to a group of 
315 patients with bladder cancer; 127 with a 
native bladder, 66 treated with cystectomy 
and ileal conduit diversion, and 122 with 
cystectomy and neobladder diversion. 
Patients with native bladders uniformly had 
higher adjusted urinary, bowel and sexual 
function domain scores than those 
undergoing orthotopic diversion (Table 3) 
[12]. Patients undergoing ileal conduit and 
orthotopic diversion had similar adjusted 
bowel and sexual function scores. Patients 
with ileal conduit diversion had significantly 
higher functional urinary domain scores than 
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12 additional bladder cancer-specific 
items including incontinence, diarrhoea, body image, sexual function, and stoma care); FACT-G; FACT–General; FACT-VCI, FACT–Vanderbilt Cystectomy Index 
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Outcomes Study 36-Item Short Form.
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bother in both groups was similar. Overall, the 
BCI showed functional and bother differences 
in patients with bladder cancer treated with 
various approaches. Longitudinal studies are 
forthcoming.
 
SURVIVORSHIP IN PATIENTS WITH 
BLADDER CANCER
 
In the 1940s and 50s, when radical 
cystectomy was being popularized by 
Marshall and Whitmore [20], the concept of 
cancer therapy encompassed large operations 
with multi-organ resection. Over the past 
10–20 years the preservation of organ 
function coupled with local cancer control 
has become a major objective of urological 
oncologists. The logical extension of this 
conceptual practice is the restoration of QoL 
after cancer surgery. Previously, postoperative 
adjustment to changes in body image, sexual 
function, urinary function and self-esteem 
were unevaluated, and to some degree, 
ignored. Continued improvements in urinary 
diversion must consider health-related QoL 
and other aspects of long-term survivorship 
that have become increasingly important.
More recently, survivorship clinics have 
been established to facilitate psychosocial 
rehabilitation. Multidisciplinary teams 
consisting of nursing professionals, sex 
therapists, social workers, and urological 
oncologists collaborate on methods to reduce 
patient stress, diminish fear, improve sexual 
and urinary function, and regain a sense of 
well-being. Such clinics are models for 
potential psychosocial interventions that can 
assist in the psychosocial recovery of patients 
undergoing urinary diversion.
Some remain sceptical about the impact of 
psychosocial interventions in the urinary 
diversion population, although there might be 





[21] randomized 50 patients with a diversion 
(17 ileal conduit, 17 continent cutaneous, and 
16 neobladders) to undergo a psychosocial 
intervention, comprising weekly counselling 
4–9 weeks after surgery. All patients were 
evaluated with the Sickness-Impact Profile 
(SIP) and the meta-contrast technique (MCT), 
an analysis used to reflect individual 
defensive strategies at the subconscious or 
unconscious level. The patient’s general 
philosophical outlook was recorded before 
and after surgery. They found no significant 
difference in the results of the SIP between 
the intervention and the no-intervention 
groups. In a subset analysis, the intervention 
appeared to benefit patients with continent 
cutaneous diversion, who had significantly 
lower psychosocial scores than those with a 
conduit or neobladder. Analyses from the MCT 
did not distinguish the intervention from the 
no-intervention group. Despite little overall 
impact of these generalized interventions, it 
might be that interventions tailored to 
specific patients with bladder cancer will 




Like other cancer survivors, patients with 
bladder cancer also have concerns about 
receiving adequate follow-up care. To address 




Hurdles in QoL studies
 
Variable Limitation Remedy
QoL instruments Previously unvalidated All instruments must have proper psychometric evaluation.
Lack of sensitivity to discern intergroup 
differences
Optimize the content and number of survey items.
Questionnaire administration Similar surveys yield differing results 
based on mode of survey 
administration
Standardized administration by a neutral party
Single-institution study Lack of general applicability Multicentre study with academic and community- based subjects
Small samples in comparison groups Statistical power Multicentre study
Retrospective study Selection bias Prospective study
Cross-sectional study No baseline (pretreatment) comparison Baseline and longitudinal data collection









No IVT IVT Ileal conduit Neobladder
No. of patients 52 75 66 122
BCI score:
Urinary domain
Function 90.7‡ 89.2† 86.5* 49.8*†‡
Bother 95.4* 93.4† 88.4 86.3*†
Bowel domain
Function 82.0 88.6*† 77.6* 76.6†
Bother 93.0*‡ 92.3†¶ 80.8*† 85.7‡¶
Sexual domain
Function 45.7*‡ 42.2†¶ 20.0*† 25.5‡¶
Bother 67.4*‡ 71.7†¶ 50.3*† 49.9‡¶
 
*†‡¶The same symbol in the same row indicates a statistically significant pair-wise difference of mean 








 0.05). Scores adjusted for age, 
gender, income, education, relationship status, and follow-up time. IVT, intravesical therapy.
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Medicine (IOM) recently released two reports 
with important implications for such patients 
[22,23]. First, the 2005 IOM report suggests 
‘Intervention for consequences of cancer and 
its treatment, for example: medical problems 
such as lymphedema and sexual dysfunction; 
symptoms, including pain and fatigue; 
psychological distress experienced by cancer 
survivors, and their caregivers.’ [22] Patients 
with urinary diversions have ongoing needs 
for stoma care, as well as potential changes in 
body image and self-concept related to 
surgery [24]. Both men and women 
undergoing cystectomy report a range of 
localized side-effects, e.g. incontinence and 
sexual dysfunction [25,26]. Patients treated 
with radiotherapy can have some of the same 
problems, plus some might experience bowel 
dysfunction, such as diarrhoea, urgency or 
incontinence [27]. Effective education 
materials need to be developed to help 
patients to manage these physical concerns 
after treatment. In addition, many patients 
might need assistance with psychosocial 
concerns [28].
Besides the physical and psychosocial 
sequelae of bladder cancer, patients must 
understand their ongoing needs for follow-up 
care. Survivorship care-plans represent one 
approach to documenting previous cancer 
treatments and needs for future care [23]. 
Although such care plans are not yet in wide 
use, they hold promise as a way of assembling 
a patient’s previous cancer-related 
treatments, their history of comorbid 
conditions, and other relevant medical 
information so that it can be accessible to 
both the patient and future healthcare 
providers. The plan might document both the 
need for late toxicity monitoring, and the 
surveillance needed for cancer recurrence or 
for a second primary cancer. The IOM 
recommends that care plans clearly identify 
providers responsible for survivorship care, 
encourage disease-preventive actions 
patients should take and document patients’ 
needs for psychosocial or vocational 
assistance [23].
To date, research on health-related QoL for 
patients with bladder cancer has been limited, 
few patient education interventions exist, and 
funding for such research or intervention 
development has been marginal. Because 
some symptom concerns mentioned above 
are similar to those of patients with cancers 
at other sites (e.g. men after radical 
prostatectomy have erectile difficulties 
similar to those experienced by men after 
cystectomy), it might be possible to adapt 
patient-education materials about other 
cancers for those with bladder cancer. As 
individual institutions explore survivorship 
strategies, it will be important to embark on 
collaborative plans to develop and assess 





The development of patient-centred decision 
aids for urinary diversion will be a central 
component in the next phase of improved 
bladder cancer care. A key understanding of 
general principles in decision-making and 
in creating decision tools is necessary to 
establish a conceptual framework for this 
endeavour.
Based on the growing reports on clinical 
survival, resources for clinicians have been 
developed to improve treatment 
recommendations to patients. Nomograms 
can provide quantitative estimates of the 
probability of disease recurrence, permitting 
urologists to counsel patients about possible 
outcomes [29]. Other nomograms based on 
large international databases also predict 
recurrence after cystectomy, but with greater 
accuracy than traditional pathological staging 
[30]. However, efforts to translate data from 
nomograms or other clinical decision aids into 
patient decision aids have been limited, and 
might be further limited by difficulties many 
patients have in understanding quantitative 
data [31]. The only bladder-cancer decision-
support tool available is the American Cancer 
Society NexProfiler Treatment Options Tool 
for Bladder Cancer [32]. After patients enter 
their clinical information, the tool generates 
two reports; one lists treatment options and 
the other reports survival, progression and 
recurrence data relevant to each patient’s 
clinical situation. Such information is sorely 
needed by patients coping with both a cancer 
diagnosis and a confusing array of treatment 
options. No such tool exists to guide a 
patient’s choice of urinary diversion. Although 
health information is increasingly available on 
the Internet, the quality of information 
provided is highly variable, so it is important 
for patients to seek information from many 
sources [33,34].
Fortunately, bladder cancer clinicians and 
researchers have a large body of literature 
from both other cancers and other disease 
areas on which to draw in developing new 
patient-centred decision aids. Detailed 
guidelines have been published by the 
International Patient Decision Aids Standards 
(IPDAS) Collaboration on the best practices 
for developing patient-centred decision aids. 
The IPDAS recommendations list 12 criteria to 
consider in developing a decision aid: use of 
a systematic development process, provision 
of information about treatment options, 
presentation of probabilities, values 
clarification, use of patient stories, use of a 
guide or coach during decision-making, 
disclosure of conflicts of interest, provision of 
access to the tool via the Internet, 
presentation of options in a balanced fashion, 
use of up-to-date information on which 
patients can base their decisions, use of plain 
language, and evaluation of the effectiveness 
of the newly developed decision aid [35].
An important first step in a systematic process 
for developing a patient decision-aid for 
bladder cancer treatment such as urinary 
diversion is basic qualitative research to 
adequately understand patient values and 
concerns. While healthcare providers talk to 
patients as part of clinical care, providers 
might not understand their patients’ concerns 
as well as they think [36]. Qualitative research, 
such as studies that involve focus groups 
or in-depth interviews, conducted after 
treatment would provide an opportunity for 
patients to discuss their values and concerns 
in a less than stressful situation, and allow 
patients to report side-effects after treatment 
and other factors that might affect decisional 
regret [37]. Such information can be an 
important foundation for developing new 
decision aids that allow patients to clarify 
their values during the decision-making 
process, and provide clinicians with more 
accurate information about their patients’ 
concerns.
In addition to clarifying patient values, 
decision aids are needed that provide 
substantive information about treatment 
options, associated side-effects and 
probabilities for survival and disease 
recurrence. Another recommendation of the 
IPDAS collaboration is for the provision of 
decision aids using plain language that can be 
understood by a wide variety of patients.
Health literacy, ‘the ability to which 
individuals have the capacity to obtain, 
process, and understand health information 
services needed to make appropriate health 
 






2 0 0 8  T H E  A U T H O R S




 2 0 0 8  B J U  I N T E R N A T I O N A L
 
1 3 3 1
 
decisions’ [38], has been shown to be strongly 
related to health status and health outcomes 




65 years are more likely 
to be over-represented among persons with 
health literacy below what is considered a 
basic level [41]. Among patients with prostate 
cancer, African-Americans are also over-
represented among persons with low health 
literacy [40]. Older adults tend to have poorer 
outcomes after cystectomy than younger 
adults, after controlling for other factors [42]. 
African-Americans tend to present with 
higher-stage disease and have a worse 
prognosis than other races, perhaps because 
they tend to be treated at hospitals with fewer 
patients with bladder cancer, or by physicians 
with less experience in treating bladder cancer 
[43,44]. It might be that one way of beginning 
to address these disparities is to provide 
patient decision aids that take into account 
the lower literacy of these groups that have 
poor outcomes after cystectomy.
With the growing interest in providing 
appropriate educational materials for low-
literacy patients, several recommendations 
for developing such materials have been 
published. Materials should be written in an 
active voice, using common words and short 
sentences, and use examples to illustrate 
complex concepts. Materials should also 
include an interactive component, allowing 
the learner to demonstrate his/her mastery 
of the material and where he/she might 
need further instruction [45]. Other 
recommendations relate to formatting 
techniques, such as using serif type and 
lowercase lettering where possible, 
incorporating visual aids that help to explain 
the information being provided, and using 
headers and white space, which help low-
literacy patients parse written materials more 
effectively [45]. Materials should also be 
developed keeping in mind that many 
patients with cancer are limited in their 
ability to understand numerical information 
[31]. The IPDAS Collaboration recommends 
including patient stories in decision aids. 
Such stories might be an effective way of 
presenting complex information about 
bladder-cancer treatment options and 
prognosis in a concrete way that can be 
more easily understood by low-literacy 
patients.
As with any new patient-education 
intervention, patient decision aids for those 
with bladder cancer need to be evaluated to 
ensure that they are providing accurate 
information that is being correctly 
understood by the target audience. In 
addition, decision aids need to be re-
evaluated and revised as new treatment 
options or other information relevant to 





QoL after continent diversion has not been 
confirmed to be better than after incontinent 
diversion; this observation makes the choice 
of urinary diversion a difficult and 
challenging one for the patient and clinician. 
The development of patient decision tools 
might help to improve the process of 
selecting appropriate bladder cancer 
treatments, including the choice of urinary 
diversion, for individual patients. There are 
many reported in prostate cancer on which to 
draw upon to begin to understand the needs 
of cancer survivors and ways to study the 
specific needs of bladder cancer patients and 
survivors. Urologists, outcomes researchers 
and patient educators all have important roles 
in helping patients make decisions that: (i) 
take into account patient preferences and 
values; (ii) are based on clearly presented 
information about treatment options, clinical 
outcomes and survivorship concerns; and (iii) 
involve healthcare providers in a conversation 
that can lead to shared decision-making. 
Patients need our help in understanding how 
to live with the physical and psychosocial 
burden of their cancer diagnosis and 
treatment-related side-effects. To further 
our understanding, we will also have the 
challenge of working with policy makers and 
funders to ensure that more money is 
available to support the development of 
patient-centred programmes in this 
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